Pabla, Navjotsingh <br/><br/>
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.  [electronic resource] 

 -  The Journal of clinical investigation  Jul 2011 
 - 2709-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI45586  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetophenones--pharmacology<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Apoptosis--drug effects<br/>Benzopyrans--pharmacology<br/>Cell Line, Tumor<br/>Cisplatin--adverse effects<br/>Enzyme Activation<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Kidney--drug effects<br/>Kidney Tubules, Proximal--cytology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mice, Nude<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Neoplasm Transplantation<br/>Neoplasms--drug therapy<br/>Protein Kinase C-delta--antagonists & inhibitors<br/>Tumor Suppressor Protein p53--metabolism<br/>src-Family Kinases--metabolism